David Sturdee

4.8k total citations
95 papers, 3.3k citations indexed

About

David Sturdee is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Reproductive Medicine. According to data from OpenAlex, David Sturdee has authored 95 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Endocrinology, Diabetes and Metabolism, 40 papers in Genetics and 20 papers in Reproductive Medicine. Recurrent topics in David Sturdee's work include Menopause: Health Impacts and Treatments (46 papers), Estrogen and related hormone effects (40 papers) and Phytoestrogen effects and research (17 papers). David Sturdee is often cited by papers focused on Menopause: Health Impacts and Treatments (46 papers), Estrogen and related hormone effects (40 papers) and Phytoestrogen effects and research (17 papers). David Sturdee collaborates with scholars based in United Kingdom, United States and Australia. David Sturdee's co-authors include Nick Panay, Amos Pines, Pratima Gupta, John Studd, T. Wade‐Evans, M H Thom, Susan R. Davis, R M Basker, Myra S. Hunter and J C Davenport and has published in prestigious journals such as The Lancet, British Journal of Anaesthesia and Clinica Chimica Acta.

In The Last Decade

David Sturdee

89 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Sturdee United Kingdom 27 2.0k 1.4k 676 639 392 95 3.3k
Lynne T. Shuster United States 31 1.7k 0.8× 1.3k 0.9× 491 0.7× 885 1.4× 378 1.0× 54 3.8k
Morris Notelovitz United States 31 1.9k 0.9× 1.2k 0.9× 558 0.8× 483 0.8× 220 0.6× 155 4.1k
Stephanie S. Faubion United States 33 1.8k 0.9× 1.2k 0.9× 608 0.9× 814 1.3× 335 0.9× 161 4.0k
Tobie J. de Villiers United States 11 1.6k 0.8× 882 0.6× 613 0.9× 507 0.8× 128 0.3× 11 3.5k
Nick Panay United Kingdom 36 2.8k 1.4× 1.6k 1.2× 854 1.3× 1.3k 2.0× 276 0.7× 117 4.8k
Kerstin Landin‐Wilhelmsen Sweden 42 2.0k 1.0× 1.4k 1.1× 446 0.7× 962 1.5× 108 0.3× 127 5.8k
Jean De Schepper Belgium 38 1.3k 0.7× 1.2k 0.8× 210 0.3× 583 0.9× 146 0.4× 185 4.3k
James Liu United States 31 732 0.4× 368 0.3× 361 0.5× 881 1.4× 380 1.0× 119 2.8k
Petra Stute Switzerland 27 875 0.4× 669 0.5× 400 0.6× 580 0.9× 123 0.3× 203 2.7k
Estella C. Parrott United States 9 929 0.5× 429 0.3× 342 0.5× 584 0.9× 264 0.7× 14 1.8k

Countries citing papers authored by David Sturdee

Since Specialization
Citations

This map shows the geographic impact of David Sturdee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sturdee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sturdee more than expected).

Fields of papers citing papers by David Sturdee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sturdee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sturdee. The network helps show where David Sturdee may publish in the future.

Co-authorship network of co-authors of David Sturdee

This figure shows the co-authorship network connecting the top 25 collaborators of David Sturdee. A scholar is included among the top collaborators of David Sturdee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sturdee. David Sturdee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sturdee, David. (2014). Urogenital atrophy. Post Reproductive Health. 20(2). 73–75. 3 indexed citations
2.
Villiers, T. J. de, Amos Pines, Nick Panay, et al.. (2013). Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric. 16(3). 316–337. 204 indexed citations
3.
Sturdee, David, et al.. (2011). Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric. 14(3). 302–320. 133 indexed citations
4.
Hunter, Myra S., et al.. (2008). Culture, country of residence and subjective well-being: a comparison of South Asian mid-aged women living in the UK, UK Caucasian women and women living in Delhi, India. International Journal of Culture and Mental Health. 1(1). 44–57. 6 indexed citations
5.
Sturdee, David. (2006). Levonorgestrel intrauterine system for endometrial protection. The Journal of the British Menopause Society. 12(1_suppl). 1–3. 5 indexed citations
6.
Gupta, Pratima, David Sturdee, & Myra S. Hunter. (2006). Mid-age health in women from the Indian subcontinent (MAHWIS): general health and the experience of menopause in women. Climacteric. 9(1). 13–22. 54 indexed citations
7.
Kumar, Sudhesh, et al.. (2005). A burning mouth associated with the use of hormone replacement therapy. The Journal of the British Menopause Society. 11(1). 38–38. 6 indexed citations
8.
Sturdee, David, et al.. (2004). The acceptability of a small intrauterine progestogen-releasing system for continuous combined hormone therapy in early postmenopausal women. The Journal of the British Menopause Society. 10(2_suppl). 16–16. 8 indexed citations
10.
Sturdee, David, et al.. (2003). The Use of Food Supplements among Women Attending Menopause Clinics in the West Midlands. The Journal of the British Menopause Society. 9(1). 32–35. 5 indexed citations
11.
Sturdee, David, et al.. (2003). The use of food supplements among women attending menopause clinics in the West Midlands. The Journal of the British Menopause Society. 9(1). 32–35. 4 indexed citations
12.
Sturdee, David, et al.. (2002). Endometrial safety of a transdermal sequential estradiol-levonorgestrel combination. Climacteric. 5(2). 170–177. 11 indexed citations
13.
Sturdee, David. (2000). Hormone replacement therapy preparations. The Journal of the British Menopause Society. 6(1). 34–36. 1 indexed citations
14.
Sturdee, David. (2000). Hormone replacement therapy and the endometrium. The Journal of the British Menopause Society. 6(2_suppl). 16–16. 1 indexed citations
15.
Sturdee, David. (1997). Benefits of Membership. The Journal of the British Menopause Society. 3(2). 5–5. 2 indexed citations
16.
Sturdee, David. (1990). Hormone replacement therapy: risks and benefits.. PubMed. 234(1488). 471, 473–4. 1 indexed citations
17.
Wade‐Evans, T., et al.. (1980). Endometrial disease after treatment with oestrogens and progestogens in the climacteric.. BMJ. 280(6217). 822–824. 131 indexed citations
18.
Sturdee, David. (1979). Female and Male Climacteric: current opinion 1978. Journal of the Royal Society of Medicine. 72(7). 547–547. 4 indexed citations
19.
Sturdee, David, et al.. (1978). Physiological aspects of menopausal hot flush.. BMJ. 2(6130). 79–80. 80 indexed citations
20.
Sturdee, David, et al.. (1976). Junior hospital doctors. BMJ. 1(6005). 343.3–343. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026